SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mairéad G. McNamara, Lisa W. Le, Anne M. Horgan, Alex Aspinall, Kelly W. Burak, Neesha Dhani, Eric Chen, Mehrdad Sinaei, Glen Lo, Tae Kyoung Kim, Patrik Rogalla, Oliver F. Bathe, Jennifer J. Knox, A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma, Cancer, 2015, 121, 10
  2. 2
    Sree Harsha Tirumani, Alexandra Fairchild, Katherine M. Krajewski, Mizuki Nishino, Stephanie A. Howard, Akshay D. Baheti, Michael H. Rosenthal, Jyothi P. Jagannathan, Atul B. Shinagare, Nikhil H. Ramaiya, Anti-VEGF Molecular Targeted Therapies in Common Solid Malignancies: Comprehensive Update for Radiologists, RadioGraphics, 2015, 35, 2, 455

    CrossRef

  3. 3
    Gi-Ae Kim, Ju Hyun Shim, Sang Min Yoon, Jinhong Jung, Jong Hoon Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Yoon-Koo Kang, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis, Journal of Vascular and Interventional Radiology, 2015, 26, 3, 320

    CrossRef

  4. 4
    Ming Liu, Man-xia Lin, Ming-de Lu, Zuo-feng Xu, Ke-guo Zheng, Wei Wang, Ming Kuang, Wen-quan Zhuang, Xiao-yan Xie, Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST, European Radiology, 2015, 25, 8, 2502

    CrossRef

  5. 5
    I-Cheng Lee, Yi-Tzen Chen, Yee Chao, Teh-Ia Huo, Chung-Pin Li, Chien-Wei Su, Han-Chieh Lin, Fa-Yauh Lee, Yi-Hsiang Huang, Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice, Medicine, 2015, 94, 14, e688

    CrossRef

  6. 6
    Mi Na Kim, Beom Kyung Kim, Kwang-Hyub Han, Seung Up Kim, Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment, Expert Review of Gastroenterology & Hepatology, 2015, 9, 3, 335

    CrossRef

  7. 7
    Beom Kyung Kim, Kyung Ah Kim, Myeong-Jin Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim, Mi-Suk Park, Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization, Digestive and Liver Disease, 2015, 47, 8, 682

    CrossRef

  8. 8
    Valentina Vaira, Massimo Roncalli, Carlo Carnaghi, Alice Faversani, Marco Maggioni, Claudia Augello, Lorenza Rimassa, Tiziana Pressiani, Gaia Spagnuolo, Luca Di Tommaso, Stefano Fagiuoli, Elena Rota Caremoli, Massimo Barberis, Roberto Labianca, Armando Santoro, Silvano Bosari, MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma, Liver International, 2015, 35, 3
  9. 9
    Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi, Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma, Hepatology Research, 2015, 45, 8
  10. 10
    Luigi Bolondi, Antonio Craxi, Franco Trevisani, Bruno Daniele, Giovan Giuseppe Di Costanzo, Stefano Fagiuoli, Calogero Cammà, Paolo Bruzzi, Romano Danesi, Federico Spandonaro, Corrado Boni, Armando Santoro, Massimo Colombo, Refining sorafenib therapy: lessons from clinical practice, Future Oncology, 2015, 11, 3, 449

    CrossRef

  11. 11
    Giovan Giuseppe Di Costanzo, Giorgio de Stefano, Raffaella Tortora, Nunzia Farella, Luigi Addario, Filippo Lampasi, Alfonso Galeota Lanza, Gabriella Cordone, Michele Imparato, Nicola Caporaso, Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinoma, Future Oncology, 2015, 11, 6, 943

    CrossRef

  12. 12
    Gino Boily, Jean-Pierre Villeneuve, Luc Lacoursière, Prosanto Chaudhury, Félix Couture, Jean-François Ouellet, Réal Lapointe, Stéphanie Goulet, Normand Gervais, Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations, HPB, 2015, 17, 1
  13. 13
    Jean-Charles Nault, Frédéric Pigneur, Anaïs Charles Nelson, Charlotte Costentin, Lambros Tselikas, Sandrine Katsahian, Guoqing Diao, Alexis Laurent, Ariane Mallat, Christophe Duvoux, Alain Luciani, Thomas Decaens, Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors, Digestive and Liver Disease, 2015,

    CrossRef

  14. 14
    Rodolfo Sacco, Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma, Future Oncology, 2014, 10, 13, 2073

    CrossRef

  15. 15
    Kaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, Masaru Muraoka, Toru Nakata, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Takashi Nishimura, Ken Ueda, Teiji Kuzuya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi, Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma, Cancer, 2014, 120, 2
  16. 16
    Dong Myung Yeo, Joon-Il Choi, Young Joon Lee, Michael Y. Park, Ho Jong Chun, Hae Giu Lee, Comparison of RECIST, mRECIST, and Choi Criteria for Early Response Evaluation of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads, Journal of Computer Assisted Tomography, 2014, 38, 3, 391

    CrossRef

  17. 17
    Cai-Zhong Chen, Sheng-Xiang Rao, Ying Ding, Shu-Jie Zhang, Feng Li, Qiang Gao, Meng-Su Zeng, Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine, Hepatology International, 2014, 8, 1, 104

    CrossRef

  18. 18
    Giuseppe Salvaggio, Alessandro Furlan, Francesco Agnello, Giuseppe Cabibbo, Daniele Marin, Lydia Giannitrapani, Chiara Genco, Massimo Midiri, Roberto Lagalla, Giuseppe Brancatelli, Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results, La radiologia medica, 2014, 119, 4, 215

    CrossRef

  19. 19
    Cindy Neuzillet, Annemilaï Tijeras-Raballand, Louis de Mestier, Jérôme Cros, Sandrine Faivre, Eric Raymond, MEK in cancer and cancer therapy, Pharmacology & Therapeutics, 2014, 141, 2, 160

    CrossRef

  20. 20
    Anuj Patel, Weijing Sun, Molecular Targeted Therapy in Hepatocellular Carcinoma: From Biology to Clinical Practice and Future, Current Treatment Options in Oncology, 2014, 15, 3, 380

    CrossRef

  21. 21
    Ann Lii Cheng, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-François Geschwind, Khean L. Goh, Kwang-Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun-Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T. Poon, Chee-Kiat Tan, Tawesak Tanwandee, Gaojun Teng, Joong-Won Park, Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel, Liver International, 2014, 34, 2
  22. 22
    Marcus Alexander Wörns, Peter Robert Galle, Sorafenib for the treatment of hepatocellular carcinoma, Hepatic Oncology, 2014, 1, 2, 189

    CrossRef

  23. 23
    Ghassan K. Abou-Alfa, Sorafenib use in hepatocellular carcinoma: More questions than answers, Hepatology, 2014, 60, 1
  24. 24
    Fuhai Wang, Xiaofeng Dong, Peng Xiu, Jingtao Zhong, Honglong Wei, Zongzhen Xu, Tao Li, Feng Liu, Xueying Sun, Jie Li, T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy, Oncology Reports, 2014,

    CrossRef

  25. 25
    James J. Harding, Ghassan K. Abou-Alfa, Treating advanced hepatocellular carcinoma: How to get out of first gear, Cancer, 2014, 120, 20
  26. 26
    Anil Arora, Ashish Kumar, Treatment Response Evaluation and Follow-up in Hepatocellular Carcinoma, Journal of Clinical and Experimental Hepatology, 2014, 4, S126

    CrossRef

  27. 27
    Adeel R. Seyal, Keyur Parekh, Yuri S. Velichko, Riad Salem, Vahid Yaghmai, Tumor Growth Kinetics Versus RECIST to Assess Response to Locoregional Therapy in Breast Cancer Liver Metastases, Academic Radiology, 2014, 21, 8, 950

    CrossRef

  28. 28
    T. Shao, L. Wang, A. J. Templeton, R. Jang, F. W. Vera-Badillo, M. G. McNamara, M. Margolis, T. K. Kim, M. Sinaei, H. Shoushtari, I. F. Tannock, Use and Misuse of Waterfall Plots, JNCI Journal of the National Cancer Institute, 2014, 106, 12, dju331

    CrossRef

  29. 29
    Seiji Oguro, Satoshi Nara, Shunsuke Kondo, Shutaro Hori, Yoji Kishi, Minoru Esaki, Kazuaki Shimada, Tomoo Kosuge, Takuji Okusaka, Hidenori Ojima, A Case of Pathological Complete Response after Combination Chemotherapy by Sorafenib and Cisplatin Hepatic Arterial Infusion for an Advanced Hepatocellular Carcinoma, The Japanese Journal of Gastroenterological Surgery, 2013, 46, 12, 915

    CrossRef

  30. 30
    Michael E. Egger, Robert M. Cannon, Tiffany L. Metzger, Michael Nowacki, Larry Kelly, Cliff Tatum, Charles R. Scoggins, Glenda G. Callender, Kelly M. McMasters, Robert C.G. Martin, Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor, Journal of the American College of Surgeons, 2013, 216, 4, 845

    CrossRef

  31. 31
    Fernanda D. Gonzalez-Guindalini, Marcos P. F. Botelho, Carla B. Harmath, Kumaresan Sandrasegaran, Frank H. Miller, Riad Salem, Vahid Yaghmai, Assessment of Liver Tumor Response to Therapy: Role of Quantitative Imaging, RadioGraphics, 2013, 33, 6, 1781

    CrossRef

  32. 32
    Rodolfo Sacco, Lorenzo Faggioni, Irene Bargellini, Barbara Ginanni, Valentina Battaglia, Antonio Romano, Marco Bertini, Giampaolo Bresci, Carlo Bartolozzi, Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: Results of a pilot study, Digestive and Liver Disease, 2013, 45, 9, 776

    CrossRef

  33. 33
    Marcello Maida, Giuseppe Cabibbo, Giuseppe Brancatelli, Chiara Genco, Nicola Alessi, Claudio Genova, Piero Romano, Maurizio Raineri, Antonello Giarratano, Massimo Midiri, Calogero Cammà, Assessment of treatment response in hepatocellular carcinoma: a review of the literature, Future Oncology, 2013, 9, 6, 845

    CrossRef

  34. 34
    Riad Salem, Robert J. Lewandowski, Chemoembolization and Radioembolization for Hepatocellular Carcinoma, Clinical Gastroenterology and Hepatology, 2013, 11, 6, 604

    CrossRef

  35. 35
    Jianyong Lei, Wentao Wang, Lunan Yan, Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria, Journal of Gastrointestinal Surgery, 2013, 17, 8, 1440

    CrossRef

  36. 36
    Huzi Li, Zhi Guo, Tongguo Si, Haitao Wang, EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation, European Journal of Gastroenterology & Hepatology, 2013, 25, 5, 620

    CrossRef

  37. 37
    Yasunari Hiramine, Tsutomu Tamai, Yasushi Imamura, Yoshirou Baba, Takuya Hiwaki, Hiroka Yamashita, Yukihiko Sho, Kenji Tahara, Ichiro Kanetsuki, Hirohito Tsubouchi, Efficacy and optimal treatment sequence of Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma, Kanzo, 2013, 54, 4, 233

    CrossRef

  38. 38
    Tao Jiang, Andrew X. Zhu, Dushyant V. Sahani, Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma, Journal of Hepatology, 2013, 58, 1, 169

    CrossRef

  39. 39
    Jihye Cha, Jinsil Seong, Ik Jae Lee, Jun Won Kim, Kwang-Hyub Han, Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma, Yonsei Medical Journal, 2013, 54, 5, 1178

    CrossRef

  40. 40
    Katsutoshi Sugimoto, Fuminori Moriyasu, Kazuhiro Saito, Nicolas Rognin, Naohisa Kamiyama, Yoshihiro Furuichi, Yasuharu Imai, Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US, Liver International, 2013, 33, 4
  41. 41
    Vahid Yaghmai, Cecilia Besa, Edward Kim, Joseph L. Gatlin, Nasir A. Siddiqui, Bachir Taouli, Imaging Assessment of Hepatocellular Carcinoma Response to Locoregional and Systemic Therapy, American Journal of Roentgenology, 2013, 201, 1, 80

    CrossRef

  42. 42
    Sadahisa Ogasawara, Fumihiko Kanai, Yoshihiko Ooka, Tenyu Motoyama, Eiichiro Suzuki, Akinobu Tawada, Tetsuhiro Chiba, Osamu Yokosuka, Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma, Hepatology International, 2013, 7, 2, 703

    CrossRef

  43. 43
    G. Daniele, N. Costa, V. Lorusso, J. Costa-Maia, I. Pache, M. Pirisi, Methodological assessment of HCC literature, Annals of Oncology, 2013, 24, suppl 2, ii6

    CrossRef

  44. 44
    Massimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, Peter R. Galle, Jessica Zucman-Rossi, Rafael Bañares, Daniel Seehofer, Peter Neuhaus, Philip Johnson, Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma, European Journal of Gastroenterology & Hepatology, 2013, 25, 6, 639

    CrossRef

  45. 45
    Beom Kyung Kim, Kyung Ah Kim, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han, Seung Up Kim, Myeong-Jin Kim, Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation, European Journal of Cancer, 2013, 49, 4, 826

    CrossRef

  46. 46
    Mohamed E. Salem, Nitin Jain, Gregory Dyson, Stephanie Taylor, Sherif M. El-Refai, Minsig Choi, Anthony F. Shields, Jeffery Critchfield, Philip A. Philip, Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization, ISRN Oncology, 2013, 2013, 1

    CrossRef

  47. 47
    Jeong Heo, Tony Reid, Leyo Ruo, Caroline J Breitbach, Steven Rose, Mark Bloomston, Mong Cho, Ho Yeong Lim, Hyun Cheol Chung, Chang Won Kim, James Burke, Riccardo Lencioni, Theresa Hickman, Anne Moon, Yeon Sook Lee, Mi Kyeong Kim, Manijeh Daneshmand, Kara Dubois, Lara Longpre, Minhtran Ngo, Cliona Rooney, John C Bell, Byung-Geon Rhee, Richard Patt, Tae-Ho Hwang, David H Kirn, Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer, Nature Medicine, 2013, 19, 3, 329

    CrossRef

  48. 48
    Riad Salem, Frank H. Miller, Vahid Yaghmai, Robert J. Lewandowski, Response assessment methodologies in hepatocellular carcinoma: Complexities in the era of local and systemic treatments, Journal of Hepatology, 2013, 58, 6, 1260

    CrossRef

  49. 49
    Louise Barbier, David Fuks, Patrick Pessaux, Fabrice Muscari, Yves-Patrice Le Treut, Sandrine Faivre, Jacques Belghiti, Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study, Annals of Surgical Oncology, 2013, 20, 11, 3603

    CrossRef

  50. 50
    Gwang Hyeon Choi, Ju Hyun Shim, Min-Joo Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Yoon-Koo Kang, Yong Moon Shin, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses, Radiology, 2013, 269, 2, 603

    CrossRef

  51. 51
    Gwang Hyeon Choi, Ju Hyun Shim, Min-Joo Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Yoon-Koo Kang, Yong Moon Shin, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses, Radiology, 2013, 269, 2, 603

    CrossRef

  52. 52
    Liliana Montella, Raffaele Addeo, Gregorio Cennamo, Bruno Vincenzi, Rita Palmieri, Pasquale Sperlongano, Rossella Sperlongano, Patrizia Iodice, Paola Russo, Salvatore Del Prete, Sorafenib in Elderly Patients with Advanced Hepatocellular Carcinoma: A Case Series, Oncology, 2013, 84, 5, 265

    CrossRef

  53. 53
    Jianyong Lei, Wentao Wang, Lunan Yan, Surgical Resection versus Open-Approach Radiofrequency Ablation for Small Hepatocellular Carcinomas within Milan Criteria after Successful Transcatheter Arterial Chemoembolization, Journal of Gastrointestinal Surgery, 2013, 17, 10, 1752

    CrossRef

  54. 54
    Yozo Sato, Hirokazu Watanabe, Miyuki Sone, Hiroaki Onaya, Noriaki Sakamoto, Keigo Osuga, Masahide Takahashi, Yasuaki Arai, Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602, Upsala Journal of Medical Sciences, 2013, 118, 1, 16

    CrossRef

  55. 55
    Julien Edeline, Laurence Lenoir, Karim Boudjema, Yan Rolland, Anne Boulic, Fanny Le Du, Marc Pracht, Jean-Luc Raoul, Bruno Clément, Etienne Garin, Eveline Boucher, Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?, Annals of Surgical Oncology, 2013, 20, 8, 2518

    CrossRef

  56. 56
    Riccardo Lencioni, Chemoembolization for Hepatocellular Carcinoma, Seminars in Oncology, 2012, 39, 4, 503

    CrossRef

  57. 57
    Samina Khokher, Muhammad Usman Qureshi, Naseer Ahmad Chaudhry, Comparison of WHO and RECIST Criteria for Evaluation of Clinical Response to Chemotherapy in Patients with Advanced Breast Cancer, Asian Pacific Journal of Cancer Prevention, 2012, 13, 7, 3213

    CrossRef

  58. 58
    EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma, European Journal of Cancer, 2012, 48, 5, 599

    CrossRef

  59. 59
    Woo-Suk Chung, Kwang-Hun Lee, Mi-Suk Park, Yeo Jin Lee, Joonho Kwon, Song-Ee Baek, Myeong-Jin Kim, Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study, American Journal of Roentgenology, 2012, 199, 2, 349

    CrossRef

  60. 60
    Tomokazu Kawaoka, Hiroshi Aikata, Eisuke Murakami, Takashi Nakahara, Noriaki Naeshiro, Mio Tanaka, Yoji Honda, Daisuke Miyaki, Yuko Nagaoki, Shintaro Takaki, Akira Hiramatsu, Koji Waki, Shoichi Takahashi, Kazuaki Chayama, Evaluation of the mRECIST and a-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib, Oncology, 2012, 83, 4, 192

    CrossRef

  61. 61
    Daniele Santini, Raffaele Addeo, Bruno Vincenzi, Alice Calvieri, Liliana Montella, Marianna Silletta, Michele Caraglia, Umberto Vespasiani, Antonio Picardi, Salvatore Del Prete, Giuseppe Tonini, Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma, Expert Review of Anticancer Therapy, 2012, 12, 10, 1283

    CrossRef

  62. 62
    V. Goh, D. Sarker, S. Osmany, G. J. R. Cook, Functional imaging techniques in hepatocellular carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 6, 1070

    CrossRef

  63. 63
    C. Verslype, O. Rosmorduc, P. Rougier, Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2012, 23, suppl 7, vii41

    CrossRef

  64. 64
    Jens Ricke, Measuring the response to selective internal radiation therapy, European Journal of Cancer Supplements, 2012, 10, 3, 57

    CrossRef

  65. 65
    MingDe Lin, Olivier Pellerin, Nikhil Bhagat, Pramod P. Rao, Romaric Loffroy, Roberto Ardon, Benoit Mory, Diane K. Reyes, Jean-François Geschwind, Quantitative and Volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors Measurements: Feasibility of a Semiautomated Software Method to Assess Tumor Response after Transcatheter Arterial Chemoembolization, Journal of Vascular and Interventional Radiology, 2012, 23, 12, 1629

    CrossRef

  66. 66
    J. Wassermann, M. Bouattour, C. Dreyer, E. Raymond, S. Faivre, Thérapies ciblées dans le carcinome hépatocellulaire: indications et perspectives, Oncologie, 2012, 14, 3, 179

    CrossRef

  67. 67
    K. Takayasu, Transarterial Chemoembolization for Hepatocellular Carcinoma over Three Decades: Current Progress and Perspective, Japanese Journal of Clinical Oncology, 2012, 42, 4, 247

    CrossRef

  68. 68
    Silvia Stacchiotti, Paolo Verderio, Antonella Messina, Carlo Morosi, Paola Collini, Antonio Llombart-Bosch, Javier Martin, Alessandro Comandone, Jurado Cruz, Andrea Ferraro, Giovanni Grignani, Sara Pizzamiglio, Vittorio Quagliuolo, Piero Picci, Sergio Frustaci, Angelo Paolo Dei Tos, Paolo G. Casali, Alessandro Gronchi, Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy, Cancer, 2012, 118, 23